Updated: May 19, 2026

Shawn Cross

PCRXPacira BioSciences, Inc.SEC CIK: 0001734779
Estimated Net Worth
$3.53 Million
Last Updated: May 19, 2026 11:45 PM EST

Transaction Summary

Total Transactions32
Buy-Sell Ratio0.00
Buy Transactions0
Sell Transactions13

Transaction Volume

Total Volume-$1.04M
Net Volume$1.04M
Buy Volume$0.00
Sell Volume-$1.04M

Trade Analysis

AVG Trade Size-$36.85K
Largest Trade$0.00
Most Active MonthDec
Most Active Year2023

Trading Sentiment

OverallBullish
Recent TradeSelling
Last 90 Days-2 Trades
ConvictionMedium

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Shawn Cross has an estimated net worth of $3.53 Million. This is based on reported shares across multiple companies, which include Applied Molecular Transport Inc., BioPlus Acquisition Corp., GT Biopharma, Inc., Cyclo Therapeutics, Inc., and Pacira BioSciences, Inc..



2024 was Shawn Cross's most active year for acquiring shares with 6 total transactions. Shawn Cross's most active month to acquire stocks was the month of November. 2023 was Shawn Cross's most active year for disposing of shares, totalling 14 transactions. Shawn Cross's most active month to dispose stocks was the month of November. 2025 saw Shawn Cross paying a total of $411,250.00 for 53,597 shares, this is the most they've acquired in one year. In 2025 Shawn Cross cashed out on 68,750 shares for a total of $1,036,189.04, their largest year based on trade value.

Holdings & Transactions

PCRXpacira biosciences, inc.
Chief Financial Officer Officer
Updated: Apr 24, 2026VIEW QUOTE
Form TypeSEC Filing
-0.0512.94K$20.81-$112.72K255.34KScheduledApr 23View
-0.0412.06K$20.77-$104.23K268.28KScheduledApr 20 - 22View
0.8749.09K105.34KFeb 11View
-0.1025.00K$20.76-$215.50K231.25KScheduledDec 09 - 10View
-0.1812.06K$22.09-$266.41K56.25KScheduledNov 10View
-0.096.69K$21.38-$143.03K68.31KOct 31View
275.00K275.00KNov 01 - 04View
View
CYTHcyclo therapeutics, inc.
Updated: Mar 03, 2025VIEW QUOTE
Form TypeSEC Filing
0.2728.60K136.35KFeb 27View
0.1917.23K107.75KNov 15View
0.119.03K90.52KAug 16View
0.3424.45K97.06KJun 03View
161.52161.52K162.52KDec 27View
View
AMTIapplied molecular transport inc.
CEO & Chair the Board Director
Updated: Dec 28, 2023VIEW QUOTE
Form TypeSEC Filing
-1.001.75MDec 27View
-0.17110.80K$0.16-$18.12K545.50KNov 22View
-0.1290.45K$0.16-$14.53K656.30KNov 15View
-0.015.56K$0.23-$1.30K746.75KJun 02 - 05View
11.51692.15K$0.16-$30.74K752.31KSep 28 - 29View
668.00K668.00KMar 24View
-0.02934.00$0.50-$467.0060.16KMar 01View
-0.063.89K$1.05-$4.09K61.09KDec 02View
-0.01884.00$1.42-$1.26K64.98KSep 01View
-0.033.93K$3.01-$11.83K133.85KJun 01 - 02View
1.97102.00K153.75KMay 16View
3.64114.75K146.25KFeb 15View
31.50K31.50KDec 24View
-0.0310.00K$17.37-$255.09K300.00KScheduledAug 19 - 23View
63.00K63.00KMar 01View
View
bioplus acquisition corp.
Updated: Dec 02, 2021
Form TypeSEC Filing
View
GTBPgt biopharma, inc.
Chief Executive Officer
Updated: Mar 16, 2018VIEW QUOTE
Form TypeSEC Filing
View